Friday, May 08, 2020 9:45:41 PM
OraSure President and CEO Stephen Tang said the company began considering developing a test as COVID-19 began spreading in January and February.
The company plans to develop a SARS-CoV-2 that, like its HIV test, will be suitable for home use and can provide results in under an hour, Tang said. He said the company aims to launch the product in September. Tang said that OraSure can currently manufacture about 13 million tests per year.
He noted, however, that some official plans to safely reopen the economy call for a billion tests per year.
"We're going to have to find a way to massively scale up," he said. "We're looking to design massive manufacturing of this from the start. Our job is to find facilities and manufacturers and partners who can jump in quickly to that manufacturing environment."
He said he anticipated being able to reach "full-scale manufacturing sometime in 2021," with a target of "tens of millions to a billion units per year."
https://www.modernhealthcare.com/technology/rapid-antigen-assays-could-prove-key-addressing-sars-cov-2-testing-limitations
Recent OSUR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 12:54:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 11:13:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 11:13:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 11:12:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 08:09:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:09:03 PM
- OraSure Announces First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/06/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:27:37 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 04:00:40 PM
- OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th • GlobeNewswire Inc. • 04/22/2026 08:10:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 08:59:55 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 12:06:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 12:04:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 11:48:43 AM
- OraSure Technologies Appoints John D. Bertrand to its Board of Directors • GlobeNewswire Inc. • 04/17/2026 12:10:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/08/2026 10:34:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/30/2026 09:37:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:34:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:23:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:23:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:05:45 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/17/2026 11:57:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/17/2026 09:29:43 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/17/2026 09:12:44 PM
